Oxidative Stress and Functional Lymphocyte Development
Oxidative Stress and Functional Lymphocyte Development
批准号:
7034607
负责人:
DAVID R KARP
金额:
$26.66万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2008-03-31
关键词:
antigen presenting cellantioxidantscell linecytokinedevelopmental immunologyhelper T lymphocytehuman subjectimmunologic memorylipoxygenasemitogen activated protein kinaseoxidative stressperoxidesphlebotomyprotein kinase Crespiratory hypersensitivityshort chain fatty acidsuperoxidestissue /cell culturetocopherols
中文摘要
描述(由申请人提供):儿童哮喘患病率为
英文摘要
DESCRIPTION (provided by applicant): The prevalence of childhood asthma is
increasing dramatically in industrialized societies. The reasons for this are
not completely understood, although persistent indoor aeroallergen challenge,
exposure to industrial pollutants and tobacco smoke, and infant bronchiolitis
have all been implicated. From these studies, the concept emerges that asthma
is the result of a preponderance of accumulated risk factors occurring in a
critical sequence, at a critical time in development. Primary prevention of
asthma will result from elimination or interruption of any of these risks. One
such risk may be the balance between oxidative stress and antioxidants,
particularly in the lung. Recent evidence has suggested that oxidative stress
may influence the polarization of T cell responses in mice. The effects of
oxidative stress on the development of Th2 responses in humans are unknown, as
are the effects of antioxidants. The Specific Aims of this Project are:
1. To determine how exposure to oxidative and nitrosative stress affects the
function of various antigen presenting cells.
2. To test whether oxidative stress alters the Th1/Th2 balance of a T cell
response to antigen.
3. To determine whether antioxidant treatment of antigen presenting cells,
and/or T cells, will alter the type of T cell response to antigen.
Different types of antigen presenting cells, including monocytic cell lines and
primary cells (e.g., dendritic cells) will be subjected to relevant stressors
and tested for their ability to modulate the expression of co-stimulatory
molecules, cytokines, and chemokines. The APC that are generated under
different conditions of oxidative stress will then be tested for the ability to
support or modulate the polarization of T cell responses to Th1 or Th2.
Finally, the ability of thiol and non-thiol antioxidants to modulate the
induction of Th1 or Th2 responses will be determined. These experiments will
both answer fundamental questions about the development of immune responses,
but also provide a framework for rational clinical trials of specific
antioxidants used at critical times for the primary prevention of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
-
批准号:10348096
-
项目类别:
-
资助金额:$93.48万
-
财政年份:2017
-
负责人:DAVID R KARP
-
依托单位:
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
-
批准号:9888967
-
项目类别:
-
资助金额:$131.51万
-
财政年份:2017
-
负责人:DAVID R KARP
-
依托单位:
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
-
批准号:8813684
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2015
-
负责人:DAVID R KARP
-
依托单位:
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
-
批准号:8996136
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2015
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7941913
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
High Throughput Screening of the Autoimmune Epitome
-
批准号:7937043
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
High Throughput Screening of the Autoimmune Epitome
-
批准号:7842417
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7673591
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2008
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7345037
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2007
-
负责人:DAVID R KARP
-
依托单位:
NIAMS: CORT - Genetic Dissection of SLE--From Mouse to Man
-
批准号:8128710
-
项目类别:
-
资助金额:$147.08万
-
财政年份:2007
-
负责人:DAVID R KARP
-
依托单位:
The Function of Human AIM in Rheumatic Disease
-
批准号:6948562
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2004
-
负责人:DAVID R KARP
-
依托单位:
The Function of Human AIM in Rheumatic Disease
-
批准号:6839655
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2004
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6620515
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6418469
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6722919
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6876546
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6484673
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6216430
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6344602
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6201112
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1999
-
负责人:DAVID R KARP
-
依托单位:
海外基金